Back to Search
Start Over
The REVIVED-BCIS2 trial: percutaneous coronary intervention vs. optimal medical therapy for stable patients with severe ischaemic cardiomyopathy.
- Source :
-
European heart journal [Eur Heart J] 2022 Dec 07; Vol. 43 (46), pp. 4775-4776. - Publication Year :
- 2022
-
Abstract
- Competing Interests: Conflict of interest: R.V. received speaker's fees from Abbott Vascular and Terumo. Other author declared no conflict of interest.
Details
- Language :
- English
- ISSN :
- 1522-9645
- Volume :
- 43
- Issue :
- 46
- Database :
- MEDLINE
- Journal :
- European heart journal
- Publication Type :
- Academic Journal
- Accession number :
- 36213942
- Full Text :
- https://doi.org/10.1093/eurheartj/ehac568